Testicular cancer treatment and diagnostics abroad

Testicular cancer most often starts in germ cells, with seminoma and nonseminoma as the main groups. These groups have different treatment pathways, and mixed germ cell tumours are managed according to their nonseminoma component. A new lump, swelling or change in a testicle should be assessed promptly, even without pain. Several benign conditions can cause similar changes, so examination and ultrasound are important rather than self-diagnosis.

Assessment may include blood tumour markers, imaging and specialist surgical planning. Suspected testicular cancer is usually approached through the groin, with tissue examined after removal of the affected testicle; an ordinary needle biopsy through the scrotum is not the standard diagnostic route. Further care depends on pathology, markers, disease extent and general health. Discuss fertility and sperm banking before treatment whenever possible, as well as hormone function, appearance and follow-up. Do not postpone local assessment while arranging a consultation abroad, particularly if symptoms change rapidly.

When a testicular change needs assessment

A lump, enlargement, heaviness or persistent discomfort in a testicle or scrotum warrants prompt medical review. These findings do not necessarily mean cancer. Sudden severe testicular pain needs emergency assessment because another condition, such as torsion, may threaten the testicle. Travel arrangements should not delay this care.

Ultrasound, markers and the diagnostic operation

The clinician examines the testicles and usually arranges ultrasound. Blood tests may include AFP, beta-hCG and LDH, which help assess germ cell tumours and interpret later treatment response. Normal markers do not exclude cancer. Staging imaging is selected to evaluate possible spread; PET is not a routine initial staging test.

When cancer is suspected, the standard operation generally removes the affected testicle through an incision in the groin, called an inguinal orchidectomy. The tissue is examined to establish the diagnosis and tumour type. A scrotal incision or routine needle biopsy through the scrotum should not be substituted without specialist consideration. Testis-preserving surgery is reserved for selected circumstances.

How the tumour type guides care

A team involving urology and oncology considers seminoma or nonseminoma pathology, marker results and staging. After surgery, some patients can follow a structured surveillance plan; others need chemotherapy, further surgery or, in selected seminoma settings, radiotherapy. A single treatment sequence is not suitable for every patient.

Surveillance requires reliable attendance for agreed tests and imaging. The team should explain recurrence risk, what changes would prompt treatment and the alternatives. Recurrent disease needs a new specialist assessment that considers previous treatment rather than automatically repeating the original plan.

Fertility and long-term health

Discuss sperm banking early, ideally before treatment. The disease and its treatment can affect fertility, and an apparently healthy remaining testicle does not guarantee normal sperm production. Ask about hormone symptoms, sexual health and the option of a testicular prosthesis. Long-term follow-up may also address treatment effects and emotional wellbeing, alongside cancer monitoring.

Frequently asked questions

Can a painless lump be important?

Yes. A new testicular lump or swelling needs assessment even if it does not hurt.

Do normal tumour markers rule out cancer?

No. Markers are interpreted with examination, ultrasound and pathology, not used alone.

Will everyone need chemotherapy?

No. The tumour type, stage and other findings guide whether surveillance or additional treatment is appropriate.

When should fertility be discussed?

Before treatment whenever possible. Ask promptly about sperm banking and specialist fertility advice, without independently delaying urgent care.